NXI Therapeutics is committed to creating tomorrow’s disruptive immunotherapies for T cell-mediated autoimmune diseases and transplantation by coronin 1 modulation. NXI’s unique approach enables an auto- & allo-selective immunomodulation that retains immunocompetence against infections and cancer.
- Website
- Send an email
- Get directions
- Bookmark
- Share
- Report
- prev
- next
Location
-
Spitalstrasse 41, 4056 Basel, Switzerland
Additional address info
- Spitalstrasse 41, 4056 Basel
Canton
Facts & figures
-
Type of organizationPrivate company
-
Year of foundation2021
-
Number of employees in Switzerland1-9
Core competencies
You may also be interested in
Nerai Bioscience 
- R&D
Member
OBaris AG
- R&D
Member
Tridek-One Therapeutics SAS
- R&D
Member